Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy

Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy

Abstract Background With the aging of the population, the burden of elderly gastric cancer (EGC) increases worldwide. However, there is no consensus on the definition of EGC and the efficacy of adjuvant chemotherapy in patients with stage II EGC. Here, we investigated the effectiveness of adjuvant c...

Full description

Bibliographic Details
Main Authors: Jianping Guo, Zhizhong Xiong, Shi Yin, Yue’e Wen, Longyang Jin, Caiqin Wang, Huaxian Chen, Dandong Luo, Zijian Deng, Dayin Huang, Xianzhe Li, Biying Yi, Chaobin Mao, Lei Lian
Format: Article
Language:English
Published: BMC 2023-10-01
Series:World Journal of Surgical Oncology
Subjects:
Gastric cancer
Elderly
Adjuvant chemotherapy
Survival
Online Access:https://doi.org/10.1186/s12957-023-03185-5

Internet

https://doi.org/10.1186/s12957-023-03185-5

Similar Items